TITLE

Arterial stiffness as a noninvasive tissue biomarker of cardiac target organ damage

AUTHOR(S)
Spartano, Nicole L.; Augustine, Jacqueline A.; Lefferts, Wesley K.; Hughes, William E.; Redmond, Jessica Garay; Martin, Eileen D.; Kuvin, Jeffrey T.; Gump, Brooks B.; Heffernan, Kevin S.
PUB. DATE
January 2014
SOURCE
Current Biomarker Findings;2014, Vol. 4, p23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The primary prevention of cardiovascular (CV) disease is hindered by the inadequacy of traditional risk factors to stratify CV risk. The presence of cardiac target organ damage (cTOD), as detected by measures of left ventricular (LV) hypertrophy and dysfunction, is associated with future CV outcomes, but is not currently assessed in asymptomatic individuals. Arterial stiffness contributes to cTOD and may represent a biomarker that can detect vascular dysfunction before the clinical manifestations of cTOD. Measurement of arterial stiffness may provide insight into premature risk for cTOD and afford opportunity for early intervention to prevent further damage. The purpose of this review is to examine the utility of arterial stiffness as a noninvasive biomarker of subclinical cTOD. To this end, we will examine the evidence supporting the association between arterial stiffness and measures of cTOD. We will then explore the developmental origins of arterial stiffness and cTOD and outline the progression of CV damage that occurs with age. We discuss the mechanistic role of pressure from wave reflections as a crucial link between arterial stiffness and cTOD. Finally, we examine these associations in context by exploring sex and racial differences in arterial stiffness as related to cTOD. Our comprehensive examination of the literature suggests that early identification of arterial stiffness would be a useful biomarker of future cTOD risk.
ACCESSION #
94734003

 

Related Articles

  • Central Hemodynamics in Risk Assessment Strategies: Additive Value Over and Above Brachial Blood Pressure. Yannoutsos, Alexandra; Rinaldi, Elisa R.; Zhang, Yi; Protogerou, Athanassios D.; Safar, Michel E.; Blacher, Jacques // Current Pharmaceutical Design;Feb2015, Vol. 21 Issue 6, p719 

    Although the clinical relevance of brachial blood pressure (BP) measurement for cardiovascular (CV) risk stratification is nowadays widely accepted, this approach can nevertheless present several limitations. Pulse pressure (PP) amplification accounts for the notable increase in PP from central...

  • Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies). Leone, Aurelio // Current Pharmaceutical Design;Dec2014, Vol. 20 Issue 39-42, p6073 

    The metabolic disorders, both as such and associated with other cardiovascular risk factors, are a group of pathological alterations in thesteady expansion with regard to their rate [1]. In addition, a clear adverse interference with the heart and blood vessels has been widelydescribed [2-5]....

  • Arterial Stiffness: From Physiology to Clinical Implications. Milan, Alberto; Tosello, Francesco; Fabbri, Ambra; Vairo, Alessandro; Leone, Dario; Chiarlo, Michela; Covella, Michele; Veglio, Franco // High Blood Pressure & Cardiovascular Prevention;Mar2011, Vol. 18 Issue 1, p1 

    Current European guidelines for the management of arterial hypertension introduce the assessment of arterial stiffness by pulse wave velocity (PWV) as an index of hypertension-related cardiovascular target organ damage. An increase in arterial stiffness is related to haemodynamic modifications...

  • MDCT Evaluation of Cardiac Involvement in Hypereosinophilic Syndrome. Chuan-Han Chen; I-Chen Tsai; Sheng-Ling Jan; Wei-Lin Tsai; Clayton Chi-Chang Chen // Texas Heart Institute Journal;2011, Vol. 38 Issue 2, p166 

    Hypereosinophilic syndrome is a rare disease that can cause multiple-organ damage. Cardiac involvement, which presents as myocardial necrosis, infarction, or thrombus formation, is the leading cause of morbidity and death. Here, we present the case of a 17-year-old girl who had hypereosinophilic...

  • Role of Antihypertensive Drugs in Arterial 'De-Stiffening' and Central Pulsatile Hemodynamics. Koumaras, Charalambos; Tzimou, Maria; Stavrinou, Eirini; Griva, Theodora; Gossios, Thomas D.; Katsiki, Niki; Athyros, Vasilios G.; Mikhailidis, Dimitri P.; Karagiannis, Asterios // American Journal of Cardiovascular Drugs;2012, Vol. 12 Issue 3, p143 

    Arterial stiffness is an independent predictor of cardiovascular (CV) morbidity and mortality in patients with hypertension, as well as a potential therapeutic target. There is increasing awareness that the pulsatile hemodynamics (central blood pressure [CBP], pulse pressure [PP], wave...

  • Arterial Stiffness and Cardiovascular Drugs. Weber, Thomas; Auer, Johann; Eisserer, Geza; Berent, Robert; Eber, Bernd; O'Rourke, Michael F. // Current Pharmaceutical Design;May2003, Vol. 9 Issue 13, p1049 

    Arterial stiffness is the most important cause of increasing systolic and pulse pressure, and for decreasing diastolic pressure with ageing. Many measures can be applied to quantify arterial stiffness, but all are approximations only, on account of the nonhomogenous structure of the arterial...

  • Functional and Structural Alterations of Large Arteries: Methodological Issues. Bianchini, Elisabetta; Giannarelli, Chiara; Maria Bruno, Rosa; Armenia, Sabina; Landini, Linda; Faita, Francesco; Gemignani, Vincenzo; Taddei, Stefano; Ghiadoni, Lorenzo // Current Pharmaceutical Design;Apr2013, Vol. 19 Issue 11-14, p2390 

    Ultrasound assessment of vascular biomarkers has been implemented for screening, prevention and improvement of cardiovascular risk stratification beyond classical risk factors including smoking, diabetes, hypercholesterolemia and hypertension. Thus, the presence of vascular damage at the...

  • Functional and Structural Alterations of Large Arteries: Methodological Issues. Bianchini, Elisabetta; Giannarelli, Chiara; Bruno, Rosa Maria; Armenia, Sabina; Landini, Linda; Faita, Francesco; Gemignani, Vincenzo; Taddei, Stefano; Ghiadoni, Lorenzo // Current Pharmaceutical Design;Apr2013, Vol. 19 Issue 11-13, p2390 

    Ultrasound assessment of vascular biomarkers has been implemented for screening, prevention and improvement of cardiovascular risk stratification beyond classical risk factors including smoking, diabetes, hypercholesterolemia and hypertension. Thus, the presence of vascular damage at the...

  • Acute Coronary Syndrome: Diagnostic Evaluation. BARSTOW, CRAIG; RICE, MATTHEW; McDIVITT, JONATHAN D. // American Family Physician;2/1/2017, Vol. 95 Issue 3, p170 

    Myocardial infarction (MI), a subset of acute coronary syndrome, is damage to the cardiac muscle as evidenced by elevated cardiac troponin levels in the setting of acute ischemia. Coronary artery disease is the leading cause of mortality in the United States. Chest pain is a common presentation...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics